Quidel earnings beat by $0.12, revenue topped estimates

Quidel (NASDAQ: QDEL) reported Q2 EPS of $0.12 and revenue of $614M, both exceeding analyst estimates of $0.00 and $609.92M respectively. The company also issued FY 2025 guidance, projecting EPS of $2.07-$2.57 and revenue of $2.60B-$2.81B. Despite the Q2 beat, QDEL's stock has significantly underperformed, down over 34% in the last three months, and has seen six negative EPS revisions recently, with InvestingPro assessing its financial health as "fair" and not a top undervalued pick.

Analysis

Quidel (QDEL) reported second-quarter results that surpassed analyst expectations, with an EPS of $0.12 against a consensus of $0.00 and revenue of $614M versus an estimated $609.92M. Despite these positive backward-looking results, the market sentiment remains decidedly bearish, as evidenced by the stock's severe underperformance, with a -34.84% decline over the last three months and a -40.90% drop over the past year. This negative momentum appears driven by forward-looking concerns. The company's FY 2025 guidance for both EPS ($2.07-$2.57) and revenue ($2.60B-$2.81B) presents midpoints that fall slightly below current analyst consensus ($2.40 and $2.72B, respectively), suggesting a weaker outlook than anticipated. This is further compounded by a significant deterioration in analyst sentiment, with six negative EPS revisions against zero positive revisions in the last 90 days. The company's underlying condition, rated as "fair performance" by InvestingPro, and its failure to be flagged as a top undervalued pick by AI algorithms, suggest that the recent price drop may not yet represent a compelling value opportunity.

Key Decisions for Investors

• Investors should treat the Q2 earnings beat with caution, as the market is clearly prioritizing the stock's severe price depreciation and weak forward-looking signals over the backward-looking results.
• Pay close attention to the FY2025 guidance, which is centered below consensus, and the trend of six recent negative EPS revisions, as these are the primary drivers of the current bearish sentiment.
• Despite a 35% price drop in three months, the stock may not be a deep value opportunity, given its 'fair' financial health score and lack of identification as an undervalued gem by AI analysis.
• A neutral or underweight position may be warranted until there are clearer signs of a fundamental turnaround, such as upward analyst revisions or guidance that confidently exceeds expectations.